新临床实践指南引入后院前疼痛管理的变化趋势
该研究基于以色列国防军创伤登记处2008至2020年数据,比较2013年镇痛临床实践指南引入前后院前镇痛情况。共纳入5,653例伤员,指南引入前6年1,084例中289例(26.7%)接受镇痛,引入后7年4,569例中1,578例(34.5%)接受镇痛(p<0.001)。指南引入后,口腔黏膜芬太尼枸橼酸盐用于41.8%的接受镇痛伤员,2020年成为最常用镇痛药(占接受镇痛伤员的61.1%)。静脉吗啡使用率从22.6%显著降至16%(p<0.001)。作者认为,这一变化可能与指南引入及口腔黏膜芬太尼枸橼酸盐在医疗队中的实施有关。
要点
- 指南引入后,院前镇痛率从26.7%(289/1,084)升至34.5%(1,578/4,569),p<0.001。
- 口腔黏膜芬太尼枸橼酸盐用于41.8%的接受镇痛伤员,2020年占接受镇痛伤员的61.1%。
- 静脉吗啡使用率从22.6%降至16%,p<0.001。
- 作者认为,镇痛率增加可能与指南引入及口腔黏膜芬太尼枸橼酸盐的实施有关。
适用人群与场景
- 以色列国防军创伤登记处2008至2020年记录的所有伤员。
处置流程与药物剂量
- 2013年6月,以色列国防军医疗队引入疼痛管理临床实践指南,推荐口腔黏膜芬太尼枸橼酸盐和低剂量静脉/肌内注射氯胺酮。
研究设计与关键结果
- 研究类型为基于以色列国防军创伤登记处的回顾性分析,共纳入5,653例伤员。
- 指南引入前6年(2008年至2013年),1,084例伤员中289例(26.7%)接受镇痛治疗;引入后7年,4,569例伤员中1,578例(34.5%)接受镇痛治疗(p<0.001)。
- 指南引入后,口腔黏膜芬太尼枸橼酸盐用于41.8%的接受镇痛伤员;2020年,口腔黏膜芬太尼枸橼酸盐成为最常用镇痛药,占接受镇痛伤员的61.1%。
- 静脉吗啡使用率从22.6%显著降至16%(p<0.001)。
证据类型、等级与局限
- 证据类型:治疗/管理类研究,证据等级为level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,镇痛率增加可能与疼痛管理临床实践指南的引入及口腔黏膜芬太尼枸橼酸盐在医疗队中的实施有关。
- 作者认为,口腔黏膜芬太尼枸橼酸盐被视为安全且易用的镇痛药,可能促进了医疗提供者的使用,从而整体提高镇痛率。
指南或共识出处
- 指南名称:疼痛管理临床实践指南;发布机构:以色列国防军医疗队;发布年份:2013年6月。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Early pain treatment following injury has been shown to improve long-term outcomes, while untreated pain can facilitate higher posttraumatic stress disorder rates and worsen outcomes. Nonetheless, trauma casualties frequently receive inadequate analgesia. In June 2013, a new clinical practice guideline (CPG) regarding pain management was introduced in the Israel Defense Forces (IDF) Medical Corps, recommending oral transmucosal fentanyl citrate (OTFC) and low-dose intravenous (IV)/intramuscular ketamine. The purpose of this study was to examine trends in prehospital pain management in the IDF.
METHODS: All cases documented in the IDF trauma registry between 2008 and 2020 were examined. This study compared casualty parameters before and after the introduction of analgesia CPG in 2013. Parameters compared included demographics, injury parameters, treatment modalities, and types of analgesia provided.
RESULT: Overall, 5,653 casualties were included in our study. During the 6 years before the introduction of the CPG, 289 (26.7%) of 1,084 casualties received an analgesic treatment, compared with 1,578 (34.5%) of 4,569 casualties during the 7 years following (p < 0.001). Since its introduction, OTFC was administered to 41.8% of all casualties who received analgesia and became the most used analgesic drug in 2020 (61.1% of casualties receiving analgesia). The rate of IV morphine significantly decreased after 2013 (22.6-16%, p < 0.001).
CONCLUSION: Pain management has become more common in trauma patients' prehospital care in the IDF in recent years. There has been a significant increase in analgesia administration, with the increased use of OTFC, along with a significant reduction in the use of IV morphine. These results may be attributed to introducing a pain management CPG and implementing OTFC among medical teams. The perception of OTFC as a safe user-friendly analgesic may have contributed to its use by medical providers, increasing analgesia rates overall.
LEVEL OF EVIDENCE: Therapeutic/care management, level III.
参考来源
- Vysokovsky M, Avital G, Betelman-Mahalo Y, et al. Trends in prehospital pain management following the introduction of new clinical practice guidelines. J Trauma Acute Care Surg. 2021. PMID: 34039920. doi:10.1097/TA.0000000000003287
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。